PMID: 6403786Mar 14, 1983Paper

Tumor selective enhancement of radioactivity uptake in mice treated with alpha-difluoromethylornithine prior to administration of 14C-putrescine

Life Sciences
J E ChaneyG A Digenis

Abstract

A group of EMT6 tumor bearing male BALB/c mice which had been treated with alpha-difluoromethylornithine (DFMO, a specific, irreversible inhibitor of ornithine decarboxylase, the enzyme which catalyzes the biosynthesis of putrescine), 8 mg/mouse, ip, 20 and 5 hrs before the 14C-putrescine dose, and a group of control animals were administered 14C-putrescine (0.5 muCi, 0.1 mCi/mmol, iv) 60 min prior to sacrifice. Radioactivity uptake data was obtained for the tumor and 13 major normal organs. In the control animals the tumor exhibited one of the highest uptakes of radioactivity. For DFMO-pretreated mice the radioactivity distribution among most of the normal tissues was not very different from that obtained for the control animals. However, the uptake into the tumor was enhanced by a factor of approximately 4. So, high tumor-to-tissue ratios (3.8, lung to 38, brain) were attained as a result of DFMO treatment.

Citations

Jan 1, 1995·Journal of Neuro-oncology·E S RedgateM Deutsch
Jan 1, 1986·Journal of Neuro-oncology·S S GoldmanE S Flamm
Jan 1, 1990·The International Journal of Biochemistry·N Seiler, F Dezeure
Jan 1, 1986·International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes·D R HwangM J Welch
May 1, 1995·The International Journal of Biochemistry & Cell Biology·A E PeggJ K Coward
Aug 1, 1996·The International Journal of Biochemistry & Cell Biology·N SeilerJ P Moulinoux
Jan 1, 1990·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·D R HwangD Kadmon
Jan 27, 1995·The Journal of Biological Chemistry·M LessardR Poulin
Jan 1, 1988·Journal of Cancer Research and Clinical Oncology·N SeilerF Gerhart
Mar 16, 2013·Molecular and Cellular Biochemistry·Gérard LescoatFrançois Gaboriau
Nov 1, 2002·Journal of Medicinal Chemistry·Jean-Guy DelcrosPhilippe Uriac

❮ Previous
Next ❯

Related Concepts

Related Feeds

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.